Patients suffering from chronic conditions do not reliably take their oral medications, leading to significantly worse health outcomes. These medications also lack patient personalisation and their efficacy is impacted by gut health and first pass liver metabolism. Based on research at the University of Melbourne and Monash Institute of Pharmaceutical Sciences, Remagine Labs’ wearable electro-pharmaceutical is revolutionising healthcare with a bluetooth connected, wearable electro-pharmaceutical that will provide patient-centered care and consistent dosing of medications to provide piece-of-mind to healthcare consumers worldwide.